Expanding Indications for Liver Transplant: Tumor and Patient Factors

키워드

참고문헌 (119)

1. Chu KK, "Low-volume deceased donor liver transplantation alongside a strong living donor liver transplantation service", World J Surg, 38, pp.1522~1528 (2014)
2. Jones PD, "Liver transplantation in 2013 : challenges and controversies", Minerva Gastroenterol Dietol, 59, pp.117~131 (2013)
3. Hashikura Y, "Successful living-related partial liver transplantation to an adult patient", Lancet, 343, pp.1233~1234 (1994)
4. Lo CM, "Extending the limit on the size of adult recipient in living donor liver transplantation using extended right lobe graft", Transplantation, 63, pp.1524~1528 (1997)
5. Strong RW, "Successful liver transplantation from a living donor to her son", N Engl J Med, 322, pp.1505~1507 (1990)
6. Starzl TE, "Orthotopic homotransplantation of the human liver", Ann Surg, 168, pp.392~415 (1968)
7. De Vreede I, "Prolonged diseasefree survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma", Liver Transpl, 6, pp.309~316 (2000)
8. Sapisochin G, "“Very early” intrahepatic cholangiocarcinoma in cirrhotic patients:should liver transplantation be reconsidered in these patients?", Am J Transplant, 14, pp.660~667 (2014)
9. Gedaly R, "Liver transplantation for the treatment of liver metastases from neuroendocrine tumors : an analysis of the UNOS database", Arch Surg, 146, pp.953~958 (2011)
10. Le Treut YP, "Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection : a 213-case European liver transplant registry study", Ann Surg, 257, pp.807~815 (2013)
11. Nguyen NT, "Neuroendocrine liver metastases and orthotopic liver transplantation : the US experience", Int J Hepatol, 2011, pp.742890~ (2011)
12. Hagness M, "Liver transplantation for nonresectable liver metastases from colorectal cancer", Ann Surg, 257, pp.800~806 (2013)
13. Toso C, "Liver transplantation for colorectal liver metastasis : survival without recurrence can be achieved", Liver Transpl, 23, pp.1073~1076 (2017)
14. Carrion AF, "Patient selection for liver transplantation", Expert Rev Gastroenterol Hepatol, 7, pp.571~579 (2013)
15. Couetil JP, "Combined lung and liver transplantation in patients with cystic fibrosis : a 4 1", 2-year experience, 1995, pp.110, 1415~1422
16. Papafragkakis H, "Combined liver and kidney transplantation", Curr Opin Organ Transplant, 15, pp.263~268 (2010)
17. Bryant R 3rd, "Contemporary outcomes of combined heart-liver transplant in patients with congenital heart disease", Transplantation, 102, pp.e67~ (2018)
18. Mazzaferro V, "Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis", N Engl J Med, 334, pp.693~699 (1996)
19. Mazzaferro V, "Milan criteria in liver transplantation for hepatocellular carcinoma : an evidence-based analysis of 15 years of experience", Liver Transpl, 17(Suppl 2), pp.S44~S57 (2011)
20. Yao FY, "Liver transplantation for hepatocellular carcinoma : expansion of the tumor size limits does not adversely impact survival", Hepatology, 33, pp.1394~1403 (2001)
21. Yao FY, "Liver transplantation for hepatocellular carcinoma : validation of the UCSF-expanded criteria based on preoperative imaging", Am J Transplant, 7, pp.2587~2596 (2007)
22. Patel SS, "Milan criteria and UCSF criteria : a preliminary comparative study of liver transplantation outcomes in the United States", Int J Hepatol, 2012, pp.253517~ (2012)
23. Fan J, "Liver transplantation outcomes in 1, 078 hepatocellular carcinoma patients : a multi-center experience in Shanghai, China", J Cancer Res Clin Oncol, 135, pp.1403~1412 (2009)
24. Lee SG, "Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center", Liver Transpl, 14, pp.935~945 (2008)
25. Mazzaferro V, "Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria : a retrospective, exploratory analysis", Lancet Oncol, 10, pp.35~43 (2009)
26. Sugawara Y, "Living donor liver transplantation for hepatocellular carcinoma : Tokyo University series", Dig Dis, 25, pp.310~312 (2007)
27. Zheng SS, "Liver transplantation for hepatocellular carcinoma : Hangzhou experiences", Transplantation, 85, pp.1726~1732 (2008)
28. Xu X, "Liver transplantation for hepatocellular carcinoma beyond the Milan criteria", Gut, 65, pp.1035~1041 (2016)
29. Xu X, "Orthotopic liver transplantation for patients with hepatocellular carcinoma complicated by portal vein tumor thrombi", Hepatobiliary Pancreat Dis Int, 3, pp.341~344 (2004)
30. Choi HJ, "The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation", Liver Transpl, 23, pp.1023~1031 (2017)
31. Choi JY, "The possibility of radiotherapy as downstaging to living donor liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus", Liver Transpl, 23, pp.545~551 (2017)
32. Lee KW, "Macrovascular invasion is not an absolute contraindication for living donor liver transplantation", Liver Transpl, 23, pp.19~27 (2017)
33. Ito T, "Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation", Liver Transpl, 13, pp.1637~1644 (2007)
34. Kim JM, "Expanded criteria for liver transplantation in patients with hepatocellular carcinoma", Transplant Proc, 46, pp.726~729 (2014)
35. Shimamura T, "Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey : the 5-5-500 rule. A retrospective study", Transpl Int, 32, pp.356~368 (2019)
36. Hameed B, "Alpha-fetoprotein level > 1000 ng", mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria, 2014, pp.20, 945~951
37. Parikh ND, "Downstaging hepatocellular carcinoma : a systematic review and pooled analysis", Liver Transpl, 21, pp.1142~1152 (2015)
38. Yao FY, "Downstaging of hepatocellular cancer before liver transplant : long-term outcome compared to tumors within Milan criteria", Hepatology, 61, pp.1968~1977 (2015)
39. Bergquist A, "Epidemiology of cholangiocarcinoma", Best Pract Res Clin Gastroenterol, 29, pp.221~232 (2015)
40. Razumilava N, "Classification, diagnosis, and management of cholangiocarcinoma", Clin Gastroenterol Hepatol, 11, pp.13~21 (2013)
41. Hu HJ, "Prognostic factors and long-term outcomes of hilar cholangiocarcinoma : a singleinstitution experience in China", World J Gastroenterol, 22, pp.2601~2610 (2016)
42. DeOliveira ML, "Cholangiocarcinoma : thirty-one-year experience with 564 patients at a single institution", Ann Surg, 245, pp.755~762 (2007)
43. Jarnagin WR, "Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma", Ann Surg, 234, pp.507~517 (2001)
44. Kimura N, "Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers : outcome analysis and prognostic factors", Surgery, 162, pp.500~514 (2017)
45. Meyer CG, "Liver transplantation for cholangiocarcinoma : results in 207 patients", Transplantation, 69, pp.1633~1637 (2000)
46. Robles R, "Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma", Ann Surg, 239, pp.265~271 (2004)
47. Sudan D, "Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma", Am J Transplant, 2, pp.774~779 (2002)
48. Heimbach JK, "Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?", Surgery, 140, pp.331~334 (2006)
49. Rea DJ, "Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma", Ann Surg, 242, pp.451~458 (2005)
50. Darwish Murad S, "Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers", Gastroenterology, 143, pp.88~98 (2012)
51. Hong JC, "Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma", J Am Coll Surg, 212, pp.514~520 (2011)
52. Mantel HT, "Strict selection alone of patients undergoing liver transplantation for hilar cholangiocarcinoma is associated with improved survival", PLoS One, 11, pp.e0156127~ (2016)
53. Razumilava N, "Cholangiocarcinoma", Lancet, 383, pp.2168~2179 (2014)
54. O’Grady JG, "Liver transplantation for malignant disease : results in 93 consecutive patients", Ann Surg, 207, pp.373~379 (1988)
55. Ringe B, "The role of liver transplantation in hepatobiliary malignancy : a retrospective analysis of 95 patients with particular regard to tumor stage and recurrence", Ann Surg, 209, pp.88~98 (1989)
56. Goss JA, "Orthotopic liver transplantation for primary sclerosing cholangitis : a 12-year single center experience", Ann Surg, 225, pp.472~481 (1997)
57. de Mestier L, "Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors", Neuroendocrinology, 101, pp.105~111 (2015)
58. Coppa J, "Resection versus transplantation for liver metastases from neuroendocrine tumors", Transplant Proc, 33, pp.1537~1539 (2001)
59. Frilling A, "Liver transplantation for patients with metastatic endocrine tumors : single-center experience with 15 patients", Liver Transpl, 12, pp.1089~1096 (2006)
60. Fan ST, "Liver transplantation for neuroendocrine tumour liver metastases", HPB(Oxford), 17, pp.23~28 (2015)
61. Moris D, "Liver transplantation in patients with liver metastases from neuroendocrine tumors : a systematic review", Surgery, 162, pp.525~536 (2017)
62. Mazzaferro V, "Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?", J Hepatol, 47, pp.460~466 (2007)
63. Mazzaferro V, "The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors", Am J Transplant, 16, pp.2892~2902 (2016)
64. Yao JC, "One hundred years after"carcinoid" : epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States", J Clin Oncol, 26, pp.3063~3072 (2008)
65. Ferlay J, "Cancer incidence and mortality patterns in Europe : estimates for 40countries in 2012", Eur J Cancer, 49, pp.1374~1403 (2013)
66. Page AJ, "Advances in understanding of colorectal liver metastasis and implications for the clinic", Expert Rev Gastroenterol Hepatol, 9, pp.245~259 (2015)
67. Moris D, "Liver transplantation for unresectable colorectal liver metastases : a systematic review", J Surg Oncol, 116, pp.288~297 (2017)
68. Mühlbacher F, "Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver", Transplant Proc, 23(1 Pt 2), pp.1567~1568 (1991)
69. Penn I, "Hepatic transplantation for primary and metastatic cancers of the liver", Surgery, 110, pp.726~734 (1991)
70. Hoti E, "Liver transplantation for primary and metastatic liver cancers", Transpl Int, 21, pp.1107~1117 (2008)
71. Meyers RL, "Liver transplantation in the management of unresectable hepatoblastoma in children", Front Biosci(Elite Ed), 4, pp.1293~1302 (2012)
72. Gupta AA, "Critical review of controversial issues in the management of advanced pediatric liver tumors", Pediatr Blood Cancer, 56, pp.1013~1018 (2011)
73. Hackl C, "Liver transplantation for malignancy : current treatment strategies and future perspectives", World J Gastroenterol, 20, pp.5331~5344 (2014)
74. Rodriguez JA, "Long-term outcomes following liver transplantation for hepatic hemangioendothelioma : the UNOS experience from 1987 to 2005", J Gastrointest Surg, 12, pp.110~116 (2008)
75. Lai Q, "Hepatic epithelioid hemangioendothelioma and adult liver transplantation : proposal for a prognostic score based on the analysis of the ELTR-ELITA registry", Transplantation, 101, pp.555~564 (2017)
76. "National Institutes of Health Consensus Development Conference Statement on the Clinical Applications of Biomaterials. November 1-3, 1982", Artif Organs, 7, pp.260~265 (1983)
77. Emre S, "Liver transplantation in patients beyond age 60", Transplant Proc, 25(1 Pt 2), pp.1075~1076 (1993)
78. Oezcelik A, "Living donor liver transplantation in patients 70 years or older", Transplantation, 99, pp.1436~1440 (2015)
79. Taner CB, "Age is not a contraindication for orthotopic liver transplantation : a single institution experience with recipients older than 75 years", Hepatol Int, 6, pp.403~407 (2012)
80. Petrowsky H, "Liver transplantation in highest acuity recipients : identifying factors to avoid futility", Ann Surg, 259, pp.1186~1194 (2014)
81. Wilson GC, "Is liver transplantation safe and effective in elderly(≥70 years)recipients? A case-controlled analysis", HPB(Oxford), 16, pp.1088~1094 (2014)
82. Ikegami T, "Clinical outcomes of living donor liver transplantation for patients 65 years old or older with preserved performance status", Liver Transpl, 20, pp.408~415 (2014)
83. Aduen JF, "Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years", Mayo Clin Proc, 84, pp.973~978 (2009)
84. Gil E, "Recipient age and mortality after liver transplantation : a population-based cohort study", Transplantation, 102, pp.2025~2032 (2018)
85. Kuramitsu K, "Impact of age older than 60 years in living donor liver transplantation", Transplantation, 84, pp.166~172 (2007)
86. Levy MF, "The elderly liver transplant recipient : a call for caution", Ann Surg, 233, pp.107~113 (2001)
87. Sharpton SR, "Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes", Transplantation, 98, pp.557~562 (2014)
88. Chava SP, "Current indications for combined liver and kidney transplantation in adults", Transplant Rev(Orlando), 23, pp.111~119 (2009)
89. Schmitt TM, "Combined liverkidney and liver transplantation in patients with renal failure outcomes in the MELD era", Transpl Int, 22, pp.876~883 (2009)
90. Rana A, "The combined organ effect: protection against rejection?", Ann Surg, 248, pp.871~879 (2008)
91. Simpson N, "Comparison of renal allograft outcomes in combined liverkidney transplantation versus subsequent kidney transplantation in liver transplant recipients : analysis of UNOS Database", Transplantation, 82, pp.1298~1303 (2006)
92. Chava SP, "Indications for combined liver and kidney transplantation in children", Pediatr Transplant, 13, pp.661~669 (2009)
93. Kitajima K, "Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor", Liver Transpl, 23, pp.315~323 (2017)
94. Siddiqi OK, "Cardiac amyloidosis : an update on pathophysiology, diagnosis, and treatment", Trends Cardiovasc Med, 28, pp.10~21 (2018)
95. Olivieri NF, "Brief report : combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous beta-thalassemia", N Engl J Med, 330, pp.1125~1127 (1994)
96. Robinson MR, "Heart and heartliver transplantation in patients with hemochromatosis", Int J Cardiol, 244, pp.226~228 (2017)
97. Beal EW, "Combined heart-liver transplantation: indications, outcomes and current experience", Transplant Rev(Orlando), 30, pp.261~268 (2016)
98. Arnon R, "Liver and combined lung and liver transplantation for cystic fibrosis : analysis of the UNOS database", Pediatr Transplant, 15, pp.254~264 (2011)
99. Ikegami T, "Feasible usage of ABO incompatible grafts in living donor liver transplantation", Hepatobiliary Surg Nutr, 5, pp.91~97 (2016)
100. Lee CF, "Adult living donor liver transplantation across ABO-incompatibility", Medicine (Baltimore), 94, pp.e1796~ (2015)
101. Song GW, "ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab", Am J Transplant, 16, pp.157~170 (2016)
102. Chan SC, "Paired donor interchange to avoid ABO-incompatible living donor liver transplantation", Liver Transpl, 16, pp.478~481 (2010)
103. Jung DH, "Section 16. Update on experience in paired-exchange donors in living donor liver transplantation for adult patients at ASAN Medical Center", Transplantation, 97(Suppl 8), pp.66~S69 (2014)
104. Marín-Gómez LM, "Outcomes of domino liver transplantation : a single institution’s experience", Transplant Proc, 42, pp.644~646 (2010)
105. Stangou AJ, "Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation", N Engl J Med, 352, pp.2356~ (2005)
106. Reich DJ, "ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation", Am J Transplant, 9, pp.2004~2011 (2009)
107. Wong TC, "Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors", Liver Transpl, 22, pp.226~236 (2016)
108. Akamatsu N, "Impact of live donor age(>or=50)on liver transplantation", Transplant Proc, 39, pp.3189~3193 (2007)
109. Tanemura A, "Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation", World J Surg, 36, pp.1102~1111 (2012)
110. Lee SD, "Changes in the organ procurement system in South Korea : effects on brain-dead donor numbers", Transplant Proc, 41, pp.3551~3555 (2009)
111. Soyama A, "The current status and future perspectives of organ donation in Japan : learning from the systems in other countries", Surg Today, 46, pp.387~392 (2016)
112. Croome KP, "Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort", Liver Transpl, 23, pp.342~351 (2017)
113. Zhou J, "Early allograft dysfunction after liver transplantation with donation after cardiac death donors", Hepatobiliary Surg Nutr, 8, pp.566~568 (2019)
114. Unek T, "Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma", World J Gastroenterol, 17, pp.4206~4212 (2011)
115. Togashi J, "Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital", Hepatobiliary Surg Nutr, 5, pp.399~407 (2016)
116. Bonadio I, "Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria : long-term follow-up of a Western single institutional experience", Clin Transplant, 29, pp.425~433 (2015)
117. de Ataide EC, "Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma", Transplant Proc, 44, pp.2438~2440 (2012)
118. Kaido T, "Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma", Surgery, 154, pp.1053~1060 (2013)
119. Lei J, "Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies", J Gastrointest Surg, 16, pp.2120~2125 (2012)

관련 논문AI추천